News | Kumamoto University Discovery May Improve Infertility Treatment by Promoting Embryo Implantation
Kumamoto University researchers identified a mechanism that may improve infertility treatment by promoting embryo implantation. The work focuses on uterine prostaglandin (PG) receptors that enhance decidualization, a key step in pregnancy, and may provide new treatment targets for implantation-related infertility.
Prostaglandins are bioactive lipids known for causing fever and pain after injury, but they also have important reproductive roles, including during labor. Their role in embryo implantation was unclear. Led by Professor Yukihiko Sugimoto and Associate Professor Tomoaki Inazumi of Kumamoto University's Faculty of Life Sciences, the team found that the uterus produces PGD2 and PGE2 early in pregnancy. These activate DP and EP4 receptors and promote formation of the decidual tissue needed for implantation.
Stimulating DP or EP4 significantly enhanced decidualization and implantation efficiency. The PGD2-DP and PGE2-EP4 pathways could also compensate for each other, suggesting that DP/EP4 agonists might help women with implantation-related infertility.
Professor Sugimoto said the study creates new possibilities for fertility treatment for couples facing implantation difficulties. The findings may lead to treatments that improve pregnancy rates in patients with infertility.
News | Kumamoto University Discovery May Improve Infertility Treatment by Promoting Embryo Implantation
News | Kumamoto University Discovery May Improve Infertility Treatment by Promoting Embryo Implantation
Kumamoto University researchers identified a mechanism that may improve infertility treatment by promoting embryo implantation. The work focuses on uterine prostaglandin (PG) receptors that enhance decidualization, a key step in pregnancy, and may provide new treatment targets for implantation-related infertility.
Prostaglandins are bioactive lipids known for causing fever and pain after injury, but they also have important reproductive roles, including during labor. Their role in embryo implantation was unclear. Led by Professor Yukihiko Sugimoto and Associate Professor Tomoaki Inazumi of Kumamoto University's Faculty of Life Sciences, the team found that the uterus produces PGD2 and PGE2 early in pregnancy. These activate DP and EP4 receptors and promote formation of the decidual tissue needed for implantation.
Stimulating DP or EP4 significantly enhanced decidualization and implantation efficiency. The PGD2-DP and PGE2-EP4 pathways could also compensate for each other, suggesting that DP/EP4 agonists might help women with implantation-related infertility.
Professor Sugimoto said the study creates new possibilities for fertility treatment for couples facing implantation difficulties. The findings may lead to treatments that improve pregnancy rates in patients with infertility.
Story source:
Collected online